RxDoctor Payments Data

Kyle Mauk, DPM

Podiatrist · Birmingham, ALNPI 1639599053

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 66.6% of it on its own, with 15 other manufacturers making up the rest. Among podiatrist clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,713in general payments, 2019–2025

Across 88 payments — averaging $110.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Team 1, LLC$1K
  • Novastep Inc.$506
  • Zimmer Biomet$311
  • Avita Medical Americas, LLC$215
  • Bioventus LLC$181
  • plus $827 from 10 others

What the payments were for

  • Travel & lodging$3,48836%
  • Food & beverage$5,02552%
  • Education$1,20012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,713 in reported general payments places this provider in the 90th percentile of 59 podiatrist providers in Alabama.

See all podiatrist providers in Alabama

Medicare billing

Part B allowed, 2024
$17,437
Medicare patients
71
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate22$366
Clindamycin Hcl14$122

Paid to pharmacies, not to this prescriber.

Other podiatrist in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →